NIVF NewGenIvf Corp: Koefisien utang jangka dawa marang modal

NewGenIvf Group Limited (NIVF) operates a network of IVF centers in Asia, leveraging its presence in Kyrgyzstan, Thailand, and Cambodia to mitigate regional threats. However, the business remains vulnerable to demographic decline and changes in local legislation. This chart of the company's price action captures the 0.01 metric, while the market currently assesses management's ability to maintain profitability following its public listing.

NewGenIvf (NIVF): Utang jangka dawa marang modal saka 05.04.2024 nganti 28.10.2026

For NewGenIvf Group Limited, the current level of long-term financial dependence reflects a balance between borrowed capital and equity. This metric correlates liabilities with a maturity of over one year against the business's net capital. A low ratio minimizes bankruptcy risk but limits expansion. Given the fragmentation of the Asian reproductive medicine market, moderate leverage is essential for acquiring private practices, enabling the company to counter the expansion of state-owned networks.

Pesaing NewGenIvf Group Limited

Rasio silihan jangka dawa marang modal HCA|Tenet (THC) - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal Fresenius Medical (FMS)|SOLV: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal encompasshealth.com EHC|Universal Health Services Corp - Utang jangka dawa marang modal|DaVita HealthCare Partners (DVA) - Utang jangka dawa marang modal|RDNT - Rasio utang jangka dawa marang ekuitas|OPCH (Option Care Corp) - Rasio silihan jangka dawa marang modal|Utang jangka dawa marang ekuitas SGRY|Rasio utang jangka dawa marang ekuitas premierinc.com|National Vision - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal PGNY (Progyny Inc)|ARDT - Utang jangka dawa marang ekuitas|SEM - Rasio utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Astrana Health, Inc. ASTH|MD: Rasio silihan jangka dawa marang modal|Utang jangka dawa marang ekuitas usph.com|Pennant Group (PNTG) - Rasio utang jangka dawa marang modal|Utang jangka dawa marang modal ORGO (Organogenesis Inc.)|Kewajiban jangka dawa marang modal Nutex Health Hospitals (NUTX)|Rasio utang jangka dawa marang ekuitas AUNA (Auna SA)|Rasio utang jangka dawa marang ekuitas SBC Medical Group Holdings Inc. (SBC)|EOLS (Evolus) - Utang jangka dawa marang modal|Tanggungan utang jangka dawa marang ekuitas CHS CYH|SKIN (Beauty Health) - Utang jangka dawa marang modal|MDWD: Kewajiban jangka dawa marang modal|Utang jangka dawa marang ekuitas biote Corp.|thejoint.com (JYNT) - Rasio utang jangka dawa marang modal|DCGO: Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal P3 Health (PIII)|Rasio utang jangka dawa marang ekuitas Gain Therapeutics, Inc. (GANX)|Utang jangka dawa marang ekuitas euda.com (EUDA)|Basel Medical Group Ltd (BMGL) - Utang jangka dawa marang modal|CLGN - Kewajiban jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas Cuprina Holdings (CUPR)|CCM - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal AMS (American Shared Hospital Services, Inc.)|MRM (MEDIROM Corp) - Tanggungan utang jangka dawa marang ekuitas|ALBT - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal DHAI|Carmell Therapeutics - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal atipt.com ATIP|Rasio utang jangka dawa marang ekuitas CMAX (CareMax Medical Group)|Kindly Health - Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas ModivCare Inc.|novointegrated.com (NVOS) - Kewajiban jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas sunlinkhealth.com SSY|BACK (IMAC Holdings Inc) - Koefisien utang jangka dawa marang modal